Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy’s Competition For Perrigo’s Omeprazole Delayed Six Months

This article was originally published in The Tan Sheet

Executive Summary

Private label leader Perrigo should have an additional six months without competition from Dr. Reddy's against the firm's top-selling OTC product, the proton pump inhibitor omeprazole

You may also be interested in...



Perrigo Gains 180-Day Exclusivity With ANDA Approval For Omeprazole Magnesium PPI

Perrigo receives approval for its ANDA for a Prilosec OTC equivalent and another for a generic of Advil Fast Relief. The firm includes those products in its outlook for $1 billion in new product sales over three years.

Perrigo Gains 180-Day Exclusivity With ANDA Approval For Omeprazole Magnesium PPI

Perrigo receives approval for its ANDA for a Prilosec OTC equivalent and another for a generic of Advil Fast Relief. The firm includes those products in its outlook for $1 billion in new product sales over three years.

Perrigo Plots Nutritionals Turnaround Following Record Year

Turning around a nutritionals business saddled with high costs remains a top priority for Perrigo as it reports record overall sales in its fiscal 2009

Related Content

Topics

UsernamePublicRestriction

Register

PS102727

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel